Crystallization (Comment) | Organism |
---|---|
molecular docking of inhibitor (E)-2-(4-isopropylbenzylidene)hydrazinecarboximidamide to HemO on the back site and the heme site | Pseudomonas aeruginosa |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(E)-2-(4-isopropylbenzylidene)hydrazinecarboximidamide | compound shows a binding affinity of 5.7 microM and an MIC50 of 52.3 microg/ml against Pseudomonas aeruginosa PAO1 and increased activity against clinical isolates of Pseudomonas aeruginosa | Pseudomonas aeruginosa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Pseudomonas aeruginosa | O69002 | - |
- |